CIK 0001579428 · Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454241907
- Phone
- (212) 332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,086,500
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-21 | TABUTEAU HERRIOT Chief Executive Officer | Grant or award · Restricted Stock Units | +28,609 | 28,609 | ||
| 2025-02-14 | Pizzie Nick Chief Financial Officer | Option exercise 10b5-1 | +3,000 | $3.50 | $11K | 45,187 |
| 2025-02-14 | Pizzie Nick Chief Financial Officer | Sale 10b5-1 | −3,000 | $131.07 | $393K | 42,187 |
| 2025-02-14 | Pizzie Nick Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,000 | $3.50 | $11K | 0 |
| 2025-02-13 | Pizzie Nick Chief Financial Officer | Option exercise 10b5-1 | +12,000 | $3.50 | $42K | 54,187 |
| 2025-02-13 | Pizzie Nick Chief Financial Officer | Sale 10b5-1 | −12,000 | $129.86 | $1.6M | 42,187 |
| 2025-02-13 | Pizzie Nick Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,000 | $3.50 | $42K | 0 |
| 2025-01-03 | Coleman Mark Director | Option exercise | +9,127 | $9.00 | $82K | 57,137 |
| 2025-01-03 | Coleman Mark Director | Option exercise · Stock Option (Right to Buy) | −9,127 | 0 | ||
| 2024-11-19 | Coleman Mark Director | Option exercise | +33,410 | $5.94 | $198K | 48,010 |
| 2024-11-19 | Coleman Mark Director | Option exercise · Stock Option (Right to Buy) | −33,410 | 0 | ||
| 2024-09-11 | Saad Mark E Director | Option exercise 10b5-1 | +11,016 | $3.67 | $40K | 21,018 |
| 2024-09-11 | Saad Mark E Director | Sale 10b5-1 | −11,016 | $91.31 | $1.0M | 10,002 |
| 2024-09-11 | Saad Mark E Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,016 | 0 | ||
| 2024-08-09 | Jacobson Mark L. Chief Operating Officer | Option exercise 10b5-1 | +47,739 | $4.04 | $193K | 53,522 |
| 2024-08-09 | Jacobson Mark L. Chief Operating Officer | Sale 10b5-1 | −47,739 | $84.26 | $4.0M | 5,783 |
| 2024-08-09 | Jacobson Mark L. Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −47,739 | 0 | ||
| 2024-06-07 | Mahony Susan Director | Grant or award · Stock Option (Right to Buy) | +5,799 | 5,799 | ||
| 2024-06-07 | Coleman Mark Director | Grant or award · Stock Option (Right to Buy) | +5,799 | 5,799 | ||
| 2024-06-07 | JEFFS ROGER Director | Grant or award · Stock Option (Right to Buy) | +5,799 | 5,799 |
Page 11 of 22 · 422 trades